Search clinical trials for: Alemtuzumab GZ402673
Total 455 results
-
Genzyme, a Sanofi CompanyCompletedRelapsing Remitting Multiple SclerosisUnited States, Argentina, Australia, Belgium, Brazil, Canada, Czechia, Denmark, Germany, Israel, Italy, Mexico, Netherlands, Poland, Russian Federation, Spain, Sweden, Ukraine, United Kingdom
-
Genzyme, a Sanofi CompanyTerminatedMultiple SclerosisUnited States, Australia, Austria, Belgium, Canada, Denmark, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, United Kingdom
-
M.D. Anderson Cancer CenterLeudositeTerminatedLymphoma, B-Cell | Lymphoma, T-Cell | Lymphoma, Low-Grade | Leukemia, Lymphocytic, Acute | Leukemia, Lymphocytic, ChronicUnited States
-
Genzyme, a Sanofi CompanyTerminatedPolycystic Kidney, Autosomal DominantBelgium, Germany, Czechia, United States, Italy, Poland, Argentina, Australia, Austria, Canada, China, Denmark, France, Israel, Japan, Korea, Republic of, Netherlands, Portugal, Romania, Spain, Taiwan, Turkey, United Kingdom
-
SanofiTerminatedCongenital Cystic Kidney DiseaseGermany, Spain, United States, Australia, Belgium, Japan, Korea, Republic of, Netherlands
-
Genzyme, a Sanofi CompanyCompletedPompe Disease | Glycogen Storage Disease Type II (GSD II) | Acid Maltase DeficiencyUnited States, Belgium, Denmark, France, Germany, Netherlands, United Kingdom
-
SanofiApproved for marketing
-
German CLL Study GroupCompletedChronic Lymphocytic LeukemiaGermany
-
SanofiRecruitingGlycogen Storage Disease Type IIBelgium, United States, China, Germany, Italy, Netherlands, Spain, Taiwan, United Kingdom
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI); Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyActive, not recruitingGlycogen Storage Disease Type IIFrance
-
Genzyme, a Sanofi CompanyCompletedHuman Acid Sphingomyelinase DeficiencyUnited Kingdom, United States
-
Genzyme, a Sanofi CompanyTerminatedNon-Hodgkins LymphomaUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnLymphomaUnited States, Australia, United Kingdom, Canada, France
-
Karolinska University HospitalSchering Nordiska ABCompleted
-
Latin American Cooperative Onco-Haematology Group...UnknownMycosis Fungoides | Sezary SyndromePeru
-
Genzyme, a Sanofi CompanyTerminatedHematologic MalignanciesUnited States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II Pompe DiseaseUnited States, Belgium, Denmark, France, Germany, Netherlands, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedB Cell Chronic Lymphocytic LeukemiaUnited States
-
German CLL Study GroupCompleted
-
University Hospital MuensterUnknown
-
University of AlbertaJuvenile Diabetes Research FoundationCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedMyelodysplastic SyndromesUnited States
-
Dana-Farber Cancer InstituteBayer; Genzyme, a Sanofi CompanyCompleted
-
Ontario Clinical Oncology Group (OCOG)Sunnybrook Health Sciences Centre; Genzyme, a Sanofi CompanyCompletedAlemtuzumab and CHOP Chemotherapy for Aggressive Histological Peripheral T-Cell Lymphomas (ACCAPELA)Peripheral T-cell LymphomasCanada
-
Genzyme, a Sanofi CompanyTerminatedChronic Lymphocytic LeukemiaMacedonia, The Former Yugoslav Republic of, Bosnia and Herzegovina, Israel
-
Chronic Lymphocytic Leukemia Research ConsortiumBayerUnknownB-Cell Chronic Lymphocytic LeukemiaUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Leiden University Medical CenterRecruitingSickle Cell DiseaseNetherlands
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingNetherlands, Spain, Germany, Israel, United Kingdom, Canada, Australia, United States, Italy, Argentina, Croatia, Russian Federation, Poland, Czechia, Belgium, France, Brazil, Austria, Denmark, Mexico, Serbia, Sweden, Ukraine
-
Samuel Forrester Hunter, MD, PhDUnknownMultiple SclerosisUnited States
-
Weill Medical College of Cornell UniversityBayerCompletedT-Cell Lymphoma | Lymphoma, Non-Hodgkin'sUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedT-LGL Lymphoproliferative DisordersUnited States
-
Johns Hopkins UniversityGenzyme, a Sanofi CompanyWithdrawnChronic Inflammatory Demyelinating NeuropathyUnited States
-
National Institute of Neurological Disorders and...Completed
-
Genzyme, a Sanofi CompanyCompletedSphingomyelin LipidosisBrazil, France, Italy, United States, Germany, United Kingdom
-
University of Wisconsin, MadisonWithdrawnNew Onset Type 1 Diabetes MellitusUnited States
-
Genzyme, a Sanofi CompanyTerminatedNon-Hodgkin's LymphomaUnited States
-
Genzyme, a Sanofi CompanyCompletedLeukemia, Lymphocytic, Chronic, B-CellJapan
-
St. Jude Children's Research HospitalCompletedSevere Combined ImmunodeficiencyUnited States
-
Northwestern UniversityGenzyme, a Sanofi Company; Millennium Pharmaceuticals, Inc.Completed
-
National Cancer Institute (NCI)CompletedPeripheral T-Cell Lymphoma (PTCL) | T-Cell Prolymphocytic Leukemia | Cutaneous T Cell Lymphoma (CTCL) | T-Cell Lymphoma Relapsed | Adult T-Cell Leukemia (ATL)United States
-
Genzyme, a Sanofi CompanyCompletedLeukemia, Lymphocytic, Chronic, B-CellUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedAcute Lymphocytic LeukemiaFrance
-
Genzyme, a Sanofi CompanyCompletedSphingomyelin LipidosisUnited States, Belgium, Brazil, France, Germany, Italy, United Kingdom
-
Leeds Cancer Centre at St. James's University HospitalCompleted
-
Genzyme, a Sanofi CompanyCompletedProgressive Multiple SclerosisSpain
-
Genzyme, a Sanofi CompanyActive, not recruitingTay-Sachs Disease | Sandhoff DiseaseUnited States, Argentina, Czechia, Portugal, Russian Federation, Turkey, United Kingdom, Brazil, France, Germany, Italy, Japan, Spain
-
Goethe UniversityCompletedLymphoma, Lymphoblastic | Adult Acute Lymphocytic Leukemia T-cellGermany
-
University of AlbertaJuvenile Diabetes Research FoundationCompleted